| Dr Amber Rochelle Beardslee, DPT | |
|
Highway 491 North, Shiprock, NM 87420 | |
| (505) 368-6001 | |
| Not Available |
| Full Name | Dr Amber Rochelle Beardslee |
|---|---|
| Gender | Female |
| Speciality | Physical Therapist - Orthopedic |
| Location | Highway 491 North, Shiprock, New Mexico |
| Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1407089162 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 2251X0800X | Physical Therapist - Orthopedic | PTL.0011074 (Colorado) | Primary |
| Provider Name | Alaska Native Tribal Health Consortium |
|---|---|
| Provider Type | Part B Supplier - Clinic/group Practice |
| Provider Identifiers | NPI Number: 1437189339 PECOS PAC ID: 6709780265 Enrollment ID: O20031125000772 |
News Archive
A scientific symposium on celiac disease, "Genetic and Immune Mechanisms in Celiac Disease," will be held at the University of California, San Diego (UCSD) School of Medicine on Friday, February 10, from 8:30 a.m. to 12 noon. The symposium, hosted by UCSD's newly established William K. Warren Medical Research Center for Celiac Disease, will be held at the university's Center for Molecular Genetics conference room.
During a meeting in Atlanta on Wednesday, a "federal advisory committee issued sweeping guidelines … for a vaccination campaign against the pandemic swine flu strain, identifying more than half the U.S. population as targets for the first round of vaccinations," CNN reports (Hellerman, 7/29).
Drugged driving has been a safety issue of increasing public concern in the United States and many other countries but its role in motor vehicle crashes had not been adequately examined. In a new study conducted at Columbia University's Mailman School of Public Health, researchers assessed the association of driver drug use, as well as the combination of drugs and alcohol, with the risk of fatal crash.
Cephalon, Inc. today announced the U.S. Food and Drug Administration (FDA) has granted a priority review for its supplemental New Drug Application (sNDA) for NUVIGIL(R) (armodafinil) Tablets [C-IV], which was filed in June of this year.
YORKSHIRE Cancer Research will invest £5 million in research that will have a direct impact on cancer patients in Yorkshire, it has been announced today.
› Verified 5 days ago
| Provider Name | Southcentral Foundation |
|---|---|
| Provider Type | Part B Supplier - Clinic/group Practice |
| Provider Identifiers | NPI Number: 1780614263 PECOS PAC ID: 5496663627 Enrollment ID: O20051027000416 |
News Archive
A scientific symposium on celiac disease, "Genetic and Immune Mechanisms in Celiac Disease," will be held at the University of California, San Diego (UCSD) School of Medicine on Friday, February 10, from 8:30 a.m. to 12 noon. The symposium, hosted by UCSD's newly established William K. Warren Medical Research Center for Celiac Disease, will be held at the university's Center for Molecular Genetics conference room.
During a meeting in Atlanta on Wednesday, a "federal advisory committee issued sweeping guidelines … for a vaccination campaign against the pandemic swine flu strain, identifying more than half the U.S. population as targets for the first round of vaccinations," CNN reports (Hellerman, 7/29).
Drugged driving has been a safety issue of increasing public concern in the United States and many other countries but its role in motor vehicle crashes had not been adequately examined. In a new study conducted at Columbia University's Mailman School of Public Health, researchers assessed the association of driver drug use, as well as the combination of drugs and alcohol, with the risk of fatal crash.
Cephalon, Inc. today announced the U.S. Food and Drug Administration (FDA) has granted a priority review for its supplemental New Drug Application (sNDA) for NUVIGIL(R) (armodafinil) Tablets [C-IV], which was filed in June of this year.
YORKSHIRE Cancer Research will invest £5 million in research that will have a direct impact on cancer patients in Yorkshire, it has been announced today.
› Verified 5 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Amber Rochelle Beardslee, DPT 8750 Bell Pl, Anchorage, AK 99507-3600 Ph: (509) 859-3185 | Dr Amber Rochelle Beardslee, DPT Highway 491 North, Shiprock, NM 87420 Ph: (505) 368-6001 |
News Archive
A scientific symposium on celiac disease, "Genetic and Immune Mechanisms in Celiac Disease," will be held at the University of California, San Diego (UCSD) School of Medicine on Friday, February 10, from 8:30 a.m. to 12 noon. The symposium, hosted by UCSD's newly established William K. Warren Medical Research Center for Celiac Disease, will be held at the university's Center for Molecular Genetics conference room.
During a meeting in Atlanta on Wednesday, a "federal advisory committee issued sweeping guidelines … for a vaccination campaign against the pandemic swine flu strain, identifying more than half the U.S. population as targets for the first round of vaccinations," CNN reports (Hellerman, 7/29).
Drugged driving has been a safety issue of increasing public concern in the United States and many other countries but its role in motor vehicle crashes had not been adequately examined. In a new study conducted at Columbia University's Mailman School of Public Health, researchers assessed the association of driver drug use, as well as the combination of drugs and alcohol, with the risk of fatal crash.
Cephalon, Inc. today announced the U.S. Food and Drug Administration (FDA) has granted a priority review for its supplemental New Drug Application (sNDA) for NUVIGIL(R) (armodafinil) Tablets [C-IV], which was filed in June of this year.
YORKSHIRE Cancer Research will invest £5 million in research that will have a direct impact on cancer patients in Yorkshire, it has been announced today.
› Verified 5 days ago
Thomas A Schroeder, PT Physical Therapist Medicare: Medicare Enrolled Practice Location: Us Hwy 491 North, Shiprock, NM 87420 Phone: 505-368-6401 Fax: 505-368-6431 | |
Susanne Wesemeyer-ortiz, PT Physical Therapist Medicare: Not Enrolled in Medicare Practice Location: Us Hwy 64 Old High School Road, Shiprock, NM 87420 Phone: 505-368-5163 Fax: 505-368-5502 | |
Joseph B Strunce, PT Physical Therapist Medicare: Medicare Enrolled Practice Location: Us Hwy 491 North, Shiprock, NM 87420 Phone: 505-368-6401 Fax: 505-368-6431 | |
Ms. Denyse B Herrmann, PT Physical Therapist Medicare: Not Enrolled in Medicare Practice Location: Us Hwy 491 N, Shiprock, NM 87420 Phone: 505-368-6020 Fax: 505-368-6431 | |
Amber Lee Logan, DPT Physical Therapist Medicare: Medicare Enrolled Practice Location: Us-491, Shiprock, NM 87420 Phone: 505-368-6001 | |
Stacy L. Kantola, PT Physical Therapist Medicare: Not Enrolled in Medicare Practice Location: Us Hwy 491 North, Shiprock, NM 87420 Phone: 505-368-6401 Fax: 505-368-6431 |